ADH-6 TFA
ADH-6 TFA
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-R-1960 | 5mg | 550.00 | + Add to cart |
|
| R-R-1960 | 10mg | 980.00 | + Add to cart |
|
|
|
||||
Product description
ADH-6 TFA is a tripyridylamide compound. The self-assembly of the aggregated nucleonic domain of the mutant p53 DBD was abolished by ADH-6. ADH-6 TFA targets and dissociates mutant p53 aggregates in human cancer cells, thereby restoring p53 transcriptional activity, leading to cell cycle arrest and apoptosis. ADH-6 TFA has the potential to study cancer diseases.
| Appearance | N/A |
|---|---|
| Molecular Weight | 754.67 |
| Purity | >90% |
| CAS | N/A |
| Formula | C31H37F3N8O11 |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds of ADH-6 TFA
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


